INTRODUCTION
Cockayne syndrome (CS) is a rare autosomal recessive human disease characterized primarily by arrested post-natal growth and development (1) . Two genetic complementation groups (CS-A and CS-B) have been identified for the disease (2) . Both the CSA and CSB genes have been isolated by functional cloning strategies and mutations have been identified in these genes in afflicted individuals (3, 4) . Little is known about the function(s) of the proteins encoded by the CSA and CSB genes. The predicted amino acid sequence of CSB protein places it in a superfamily of ATPases designated the SNF/SWI family (5,6) which, among multiple other subfamilies, includes the yeast Snf2 ATPase and its human and Drosophila homologs (4) . Snf2 protein is a subunit of the multi-protein Swi-Snf complex, which is believed to function in chromatin remodeling associated with transcriptional activation in yeast (5, 6) . The predicted amino acid sequence of the human CSA gene reveals that it is a member of the WD repeat protein family (3) . WD repeat proteins are involved in various aspects of cellular metabolism, including signal transduction, vesicular trafficking, regulation of cytoskeletal assembly, cell cycle regulation, RNA processing and gene regulation (reviewed in 7). Structural models suggest that WD repeat proteins have the potential for interacting with other proteins, consistent with the observation that many such proteins are components of multi-protein complexes (reviewed in 7) .
The clinical features of CS are sometimes also observed in patients with xeroderma pigmentosum (XP), a hereditary disease which by itself manifests with a marked predisposition to skin cancer and defective nucleotide excision repair (NER) in both transcriptionally active and transcriptionally silent DNA when patients or their cells in culture are exposed to UV radiation (2) . The association of the clinical features of both CS and XP is presently confined to three of the eight known XP genetic complementation groups, XP-B, XP-D and XP-G (2), and mutations in the XPB and XPD and XPG genes have been identified in XP-B/CS, XP-D/CS and XP-G/CS individuals (8) (9) (10) . Both the XPB and XPD genes encode subunits of RNA polymerase II (RNAP II) basal transcription factor IIH (TFIIH), which is essential for RNAP II transcription initiation and is also indispensable for NER (11, 12) . A role of the XPG gene in RNAP II transcription has not been documented. However, recent studies have shown that deletion of the XPG gene in mouse cells results in early post-natal death (Y.Harada and T.Shiomi, personal communication). Hence, it would appear that, like the XPB and XPD genes, the XPG gene has a second important (if not essential) function in addition to its role in NER.
Unlike XP, CS is not related to any known environmental exposure. However, when CS cells in culture are treated with various DNA damaging agents they manifest phenotypes consistent with a defect(s) in DNA repair. The cells are abnormally sensitive to UV radiation and to a number of UV-mimetic chemicals (2) . Following exposure to UV radiation CS cells are defective in strand-specific NER (so-called transcription coupled repair), during which the rate of repair of the template (transcribed) strand of transcriptionally active genes is enhanced relative to the coding (non-transcribed) strand (13, 14) . In contrast to normal cells, CS-B cells as well as cells from the XP-G/CS complex also fail to show a kinetic preference Nucleic Acids Research, 1997, Vol. 25, No. 18 3637 for repair of the transcribed strand after exposure to ionizing radiation (15) or hydrogen peroxide (16) .
The elucidation of a role for the XPB and XPD proteins in RNAP II transcription has prompted the suggestion that the CS phenotype in XP/CS patients primarily results from abnormalities in the transcription function of these proteins (17) (18) (19) . A logical extension of this hypothesis predicts that cells from patients belonging to the CS-A and CS-B complementation groups (who do not simultaneously suffer from XP) might also fail to support normal RNAP II-mediated transcription. Indeed, reduced levels of RNAP II transcription in vivo have recently been documented in CS-B cells (20) . Defective repair that is coupled to transcription may then be a secondary phenotype observed when CS or XP/CS cells are exposed to various DNA damaging agents (21) .
In the present study we have examined the capacity of CS cells to carry out transcription by RNAP II in vitro. We have observed reduced levels of transcription driven by plasmid-borne RNAP II promoters in extracts of various CS-A and CS-B cells. Reduced transcription was corrected by mixing specific fractions of CS and normal cell extracts. Additionally, when CS-A or CS-B cells were transfected with the corresponding wild-type gene, transcription was restored to normal levels. Reduced levels of RNAP II transcription were also observed in extracts of cells from an individual with the XP-B/CS syndrome.
MATERIALS AND METHODS

Cell lines
Human lymphoid cell lines and SV40-transformed human fibroblast cell lines were obtained from the Human Genetic Mutant Cell Repository (Camden, NJ) and were shown to be free of Mycoplasma. Cells were grown in medium recommended by the Repository. The following cell lines were used: normal human lymphoblasts GM3798, GM1953, GM3714 and GM3201; CS-A lymphoblasts GM1857; CS-B lymphoblasts GM1712; XP-B/CS lymphoblasts GM2252; SV40-transformed human fibroblasts CS3BE (CS-A) and CS/1AN (CS-B); primary fibroblasts MpSI (CS-A). This cell line was kindly provided by Dr M.Yamaizumi (Kumamoto University, Japan). Stable transfectants were derived from the CS3BE (CS-A) and CS/1AN (CS-B) cell lines by transfection of the CSA and CSB genes respectively, as described previously (3).
Preparation and fractionation of whole cell extracts
Whole cell extracts were prepared essentially by the method of Manley et al. (22) . Extracts for fractionation on phosphocellulose were dialyzed overnight at 4_C against buffer A [25 mM HEPES-KOH, pH 7.9, 1 mM dithiothreitol (DTT), 1 mM EDTA, 10% glycerol, 0.01% Nonidet-P40, 0. 
DNA template for transcription
Plasmid pML(C 2 AT) was provided by Dr Roger Kornberg (Stanford University, Stanford, CA). Briefly, plasmid preparations designated as DNA I were prepared by lysozyme lysis of cells followed by clearing of the lysate. The cleared lysate was loaded onto a Qiagen column and the plasmid eluted utilizing conditions recommended by the manufacturer (Qiagen). The plasmid was purified by equilibrium centrifugation in a CsCl/ethidium bromide gradient under conditions that strictly avoided exposure of the gradients to visible light. The DNA was further purified by sucrose gradient centrifugation (23) . Plasmid preparations designated as DNA II were isolated by the SDS/alkaline lysis method and purified by equilibrium centrifugation in a CsCl/ethidium bromide gradient (24) followed by phenol/chloroform treatment and ethanol precipitation.
RNAP II transcription in vitro
Transcription reactions (50 µl) contained 2 µg supercoiled plasmid pML(C 2 AT) containing the adenovirus major late promoter (AdML) plus a G-less cassette (25) 40 -100 µg protein of unfractionated whole cell extract instead. Reactions were carried out at 30_C for 1 h, followed by treatment with RNase T 1 (10-20 U in 200 µl 10 mM Tris-HCl, pH 7.5, 0.3 M NaCl and 5 mM EDTA) for 10 min at room temperature. SDS (12.5 µl of a 10% solution) and 10 µl proteinase K (5 mg/ml) were added and reactions were incubated at 30_C for 20 min, followed by addition of 2 µl tRNA (10 mg/ml) and 0.75 ml ethanol. After 20 min at -20_C RNA was pelleted by centrifugation for 10 min in a microfuge and washed with 0.5 ml 75% ethanol. The pellet was dried under vacuum, dissolved in 20 µl formamide dye solution, heated for 5 min at 95_C and 10 µl was loaded onto a 5% polyacrylamide-7 M urea gel. Electrophoresis was carried out in Tris-borate-EDTA buffer at 45 mA and gels were washed for 20 min in distilled water, dried and subjected to autoradiography. The expected product has a length of ∼400 nt and no transcript is produced when α-amanitin is introduced into the reaction mixture.
Detection of RNAP II transcription factors by immunoblotting
Whole cell extract and phosphocellulose fractions I and II (50 µg protein) from wild-type (GM3798 or GM3201) and CS-A (GM1857) cells were resolved by SDS-PAGE and transferred to nitrocellulose membranes. Blots were probed with polyclonal rabbit antibodies (Santa Cruz Biotechnology) directed against TFIIE-α, TFIIE-β, TFIIF-RAP74, TFIIF-RAP30 and p89 of TFIIH. Horseradish peroxidase-conjugated polyclonal donkey antibody to rabbit immunoglobulin (Amersham) was used as secondary antibody and immunocomplexes were detected by enhanced chemiluminescence (ECL; Amersham). 
Measurement of DNA repair synthesis
This assay was performed as previously described (26) .
RESULTS
Reduced levels of RNAP II transcription in crude extracts
The XPB and XPD genes, which encode subunits of the RNAP II basal transcription factor TFIIH, have been implicated in the XP/CS complex (11, 12, (17) (18) (19) . A recent study demonstrated reduced levels of basal transcription in an in vitro reconstituted transcription assay supplemented with TFIIH isolated from XP-B/CS cells compared with assays supplemented with TFIIH isolated from normal cells (27) . We examined the levels of RNAP II transcription in CS and XP-B/CS cells in vitro. In initial experiments performed with crude extracts of CS-A, CS-B and XP-B/CS cells we observed reduced levels of transcription from a supercoiled plasmid carrying the AdML RNAP II promoter (Fig. 1) . More refined analysis led to the observation that reduced transcription with extracts of CS cells correlated with the particular protocol used for isolation and purification of the plasmid DNA used as the transcription template. When plasmid DNA was purified by lysis of Escherichia coli cells with lysozyme followed by CsCl/ethidium bromide gradient centrifugation under conditions that avoided exposure of the gradients to visible light and then by sucrose gradient centrifugation, we observed equivalent levels of transcription in normal, CS-A, CS-B and XP-B/CS cells ( Fig. 2A, DNA I) . We designate this DNA I. In contrast, when the plasmid DNA was isolated by SDS/alkaline lysis and purified by CsCl/ethidium bromide gradient centrifugation (without regard to exposure of the DNA to light) followed by phenol/chloroform treatment and ethanol precipitation, we consistently observed reduced levels of transcription in CS and XP-B/CS cells ( Fig. 2A, DNA II) . We designate this DNA II.
In an effort to identify differences in DNA I and II that might influence their ability to support efficient RNAP II transcription we examined these plasmids for the presence of base damage. Following incubation of equal amounts of plasmid DNA I and II with extracts that support both base excision repair (BER) and NER in vitro we observed an autoradiographic signal that was three to five times more intense in DNA II than DNA I (Fig. 2B) . DNA II is a substrate for DNA repair synthesis initiated by whole cell extract. Aliquots of 300 ng DNA I or DNA II were incubated with 100 µg whole cell extract protein for 2 h at 30_C. Plasmid DNA was purified from the reaction mixture as described in Materials and Methods, linearized with EcoRI restriction endonuclease and analyzed on a 1% agarose gel. After electrophoresis the gel was dried and subjected to autoradiography.
We also quantitated the number of sites sensitive to the DNA repair enzyme endonuclease III (which detects the presence of oxidative damage in DNA; 2) by measuring the extent of conversion of supercoiled DNA to the relaxed circular form. We observed an increase in endonuclease-sensitive sites in DNA II compared with DNA I (data not shown). The deliberate generation of transcription templates with oxidative damage by treatment of DNA with osmium tetroxide resulted in reduced levels of transcription in both normal and CS cells (J.-F.Houle and E.C.Friedberg, unpublished observations). In order to ascertain whether the presence of nicks in template DNA II was responsible for the observed defect we prepared supercoiled and nicked templates in a similar fashion to DNA I. Supercoiled and nicked templates supported similar levels of transcription and combinations of these substrates did not result in a CS extract-specific deficit as observed with template DNA II (data not shown). Based on these results all further transcription experiments described here used DNA II exclusively.
Reduced levels of RNAP II transcription in fractionated extracts
Roeder and his colleagues demonstrated that following fractionation of crude extracts by phosphocellulose chromatography RNAP II transcription activity can be reconstituted using particular fractions (28) . They showed that unspecified proteins which inhibit transcription in crude extracts are removed by such treatment, yielding fractions that support RNAP II transcription more efficiently. Similar results have been reported by others (22, 29) . We fractionated extracts of cell lines derived from normal and CS-A and CS-B individuals according to the procedure of Matsui et al. (28) . Briefly, whole cell extracts were loaded onto a phosphocellulose column in 0.1 M KCl. The flow-through was saved as fraction I (PC-FI). Bound proteins were sequentially eluted with 0.35 and 1 M KCl and the latter eluate was saved as fraction II (PC-FII). Consistent with the results of previous studies (22, 28, 29) , when PC-FI and PC-FII from normal lymphoblast lines were mixed in varying proportions with the same total amount of protein and incubated in reactions containing a supercoiled plasmid carrying the AdML promoter a transcript of the expected size was detected (Fig. 3A and B, right). Optimal levels of transcription were observed at ratios of PC-FI/PC-FII ranging between 0.4 and 4.0, depending on the particular experiment. Fractions derived from CS-A (Fig.  3A, left) or CS-B (Fig. 3B, left) showed significantly reduced levels of transcription from the AdML promoter. These results were obtained with extracts of several different immortalized lymphoblast cell lines, SV40-transformed fibroblasts (see below) and primary fibroblasts from CS-A and CS-B individuals. Appropriate exposure of autoradiograms facilitated quantitative densitometry scanning of gels. Such quantitation from multiple experiments indicates that transcription from the AdML promoter in CS extracts was reduced to levels ranging from 5 to 20% of that observed in extracts of normal cells. Reduced levels of transcription were also observed with supercoiled plasmids carrying either the SV40 or the core IgH promoter and with linear plasmids carrying the SV40 early promoter plus an enhancer sequence 
(B) Reconstitution of in vitro transcription by mixing different phosphocellulose fractions from normal (GM3798), CS-A(GM1857) and XP-B/CS (GM2252) cells. Lane 1, PC-FI and PC-FII from normal cells; lane 2, PC-FII from XP-B/CS cells with PC-FI from normal cells (designated N in this figure); lane 3, PC-FI from XP-B/CS cells with PC-FII from normal cells; lane 4, PC-FII from XP-B/CS cells with PC-FI from CS-A cells; lane 5, PC-FI from XP-B/CS cells with PC-FII from CS-A cells. Fractions PC-FI and PC-FII
were mixed at a ratio of 1.6. The total protein in each reaction was 40 µg. Reactions were carried out as in the legend to Figure 3. from human cytomegalovirus or enhancer elements from the genome of type I human T cell leukemia virus (data not shown).
RNAP II transcription in extracts of XP-B/CS cells
The combined XP/CS clinical complex is most consistently observed in patients from XP complementation group B (2). As was the case with CS-A and CS-B cells, whole cell extracts (Figs. 1 and 2A) as well as reconstituted phosphocellulose fractions of extracts from XP-B/CS lymphoblastoid cells (Fig. 4A) showed reduced levels of transcription from the AdML promoter (DNA II). This defect was not corrected by mixing PC-FII from XP-B/CS cells with PC-FI from normal cells (Fig. 4B, lane 2) or CS-A cells (Fig. 4B, lane 4) . However, the defect was corrected by mixing PC-FI from XP-B/CS cells with PC-FII from either normal (Fig. 4B, lane 3) or CS-A cells (Fig. 4B, lane 5) . Hence, the proteins defective in XP-B/CS cells on the one hand and in CS-A and CS-B cells on the other reside in different phosphocellulose fractions. In fact, we have detected the p89 subunit of TFIIH in PC-FII by Western analysis, in accordance with previously published data ( Fig. 5; 30 ). In addition, we have detected CSA protein in PC-FI by immunoblotting with an antibody prepared against CSA protein (J.-F.Houle and E.C.Friedberg, unpublished observations) (data not shown).
As is the case with extracts of CS cells, the defect in XP-B/CS cells does not derive from the acquisition of an inhibitor of in vitro RNAP II transcription, since mixing equal amounts of PC-FII from both normal and XP-B/CS cells with PC-FI from normal cells supported normal levels of transcription from the AdML promoter (Fig. 7B, lane 4 ; see text below).
Specificity of reduced RNAP II transcription
In order to eliminate the possibility that the results described above reflect aberrant chromatography of CS extracts on phosphocellulose we compared the distribution of several well-characterized RNAP II transcription factors in PC-FI and PC-FII from normal and CS cells by Western analysis. We detected equivalent amounts of TFIIE-α, TFIIE-β, TFIIF-RAP74, TFIIF-RAP30 and TFIIHp89 in PC-FII of normal and CS cells (Fig. 5) . We also observed equivalent (smaller) amounts of TFIIE-α and TFIIF-RAP30 in PC-FI of both normal and CS cells. Equivalent levels of TFIIE-α, TFIIE-β, TFIIF-RAP 74 and TFIIF-RAP 30 were also detected in the discarded 0.35 M phosphocellulose fraction of normal and CS cells (data not shown).
We carried out several experiments to show that extracts of CS cells were not non-specifically inactivated during their preparation or fractionation. First, as previously documented (13), extracts of both CS-A and CS-B cells supported normal levels of NER of UV-irradiated plasmid DNA in vitro (data not shown). Second, we examined in vitro complementation of reduced transcription by mixing different phosphocellulose fractions from CS and normal cells. Efficient transcription from the AdML promoter was restored when PC-FI from normal cells was mixed with PC-FII from CS-A (Fig. 6A, right) or CS-B (Fig. 6B, right) cells. In contrast, the reverse combination of PC-FI from CS-A (Fig. 6A, left) or CS-B cells and PC-FII from normal cells (Fig.  6B, left) did not restore normal transcription activity. When equal amounts of PC-FI from both CS-A and CS-B extracts were mixed with PC-FII from normal cells defective transcription persisted (Fig. 7A) . These results indicate that factors present in PC-FI (presumably CSA and CSB proteins) which influence RNAP II transcription in vitro are defective in both CS-A and CS-B cells. When equal amounts of PC-FI from normal and CS-A or CS-B cells were mixed with PC-FII from wild-type cells normal levels of transcription were observed from the AdML promoter (Fig.  7B, compare lanes 1, 2 and 3) . Hence, CS cells do not contain an inhibitor of in vitro RNAP II transcription.
Complementation of reduced RNAP II transcription in vitro and in vivo
In order to establish that defective RNAP II transcription in extracts of CS-A and CS-B cells results from a defect in the corresponding gene, we compared RNAP II transcription in extracts of CS cell lines transfected with a plasmid vector or with the vector carrying the cloned CSA or CSB cDNA. Transcription from the AdML promoter was fully complemented in extracts prepared from CS cells carrying the appropriate gene ( Fig. 8A  and B) .
DISCUSSION
There is no experimental evidence of which we are aware that directly implicates the CSA and CSB proteins in RNAP II transcription in human cells. Hence, our observations of reduced levels of RNAP II transcription in both crude and fractionated extracts of CS-A and CS-B cells are provocative. Similar observations have recently been made using techniques that measure RNAP II transcription in vivo in CS-B cells (20) .
The cellular phenotypes of sensitivity to UV radiation and of defective strand-specific NER after exposure to UV light have prompted speculation that defective strand-specific repair (transcriptionally coupled repair) is a primary defect in this disease (31) . It has been suggested that spontaneous base damage associated with oxidative metabolism may be concentrated in cells with unusually high metabolic rates which proliferate rapidly during development, leading to the organ-specific defects observed in the disease (31) . In support of this hypothesis, both CS-B cells (15) and more recently cells from individuals with the combined XP-G/CS complex (16) have been shown to be defective in strand-specific repair following exposure to ionizing radiation. Using a monoclonal antibody that specifically recognizes the oxidatively damaged base thymine glycol, it has been observed that CS-B cells remove thymine glycols from the overall genome as efficiently as normal cells (16) . However, whereas thymine glycols are preferentially lost from the transcribed strand of the transcriptionally active MTIA and MTIIA genes in normal and XP-A cells, CS-B cells and cells from the combined XP-G/CS complex are defective in this process (16) . These observations have led to the suggestion of a unique transcription-coupled excision repair process which requires at least the CSB and XP-G proteins (16) . It has also been suggested that the CS proteins may play a role in releasing RNAP II complexes stalled at sites of base damage in template strands of DNA, thereby serving as the eukaryotic equivalent of the E.coli mfd gene product (transcription-repair coupling factor, TCRF; 32). Recent studies with in vitro reconstituted systems have not provided support for this hypothesis. In fact, these experiments demonstrated that normal as well as CS-A and CS-B cell extracts contain an activity which can actually disrupt stalled RNAP II complexes (33) . Furthermore, purified recombinant CSB protein failed to displace stalled RNAP II complexes in vitro (34) .
The recent observations that certain eukaryotic proteins that are indispensable for NER are also essential for general transcription by RNAP II (11, 12, (35) (36) (37) (38) has led to an alternative view of the molecular pathology of CS. The 'transcription hypothesis' (17) (18) (19) suggests that the clinical features of CS result from subtle defects in transcription which are phenotypically consequential because a specific subset of genes must be expressed at certain levels during particular stages of development. This model provides an attractive explanation for cases of CS which derive directly from certain mutations in the XPB or XPD genes. The human XPB gene and its highly conserved essential yeast homolog SSL2 are known to encode subunits of the RNAP II transcription factor TFIIH (35, 39, 40) . Hence, our observation that extracts of XP-B/CS cells support reduced levels of transcription from RNAP II promoters is consistent with the known requirement of the XPB protein for RNAP II transcription (17) (18) (19) . Our additional observation that the defect in XP-B/CS cells resides in phosphocellulose fraction PC-FII is also consistent with the observation that TFIIH is contained in this fraction (30) . Indeed, recent studies have documented reduced levels of RNAP II transcription in a reconstituted in vitro system containing TFIIH purified from an XP-B/CS individual (27) .
As a refinement of the 'transcription hypothesis' it has been suggested that CS results from a defect in a process that facilitates translocation of limiting amounts of TFIIH between NER and RNAP II transcription initiation complexes (42) . Such a defect could result in inefficient conversion of TFIIH to its transcription function. There are suggestions that TFIIH may indeed be limiting in cells in certain circumstances (43) .
Our observation that the reduced transcription observed in cell-free extracts correlates with the presence of detectable base damage in the plasmid DNA used as a template for transcription is consistent with both the 'DNA repair' and 'transcription' models. The 'DNA repair hypothesis' predicts that a defect in transcription-coupled repair of base damage in CS cells would be reflected in terms of both reduced levels of transcription and reduced repair capacity. However, an alternative interpretation of our results is that the presence of base damage, or possibly other structural perturbations of the template used for transcription in vitro, accentuates specific requirements for quantitatively normal RNAP II transcription which are met by the CSA and CSB proteins. These proteins are clearly not essential for RNAP II transcription in human cells since CS individuals are viable and only manifest developmental problems after birth. However, they may affect the efficiency of this process in vivo and in vitro. The transcription model implicates deficient transcription as a primary element in the molecular pathology of CS and suggests that various structural alterations in transcriptionally active genes, including but not necessarily confined to base damage, may limit the efficiency of RNAP II transcription in CS individuals. The extent to which spontaneous DNA damage may contribute to such transcriptional stress is difficult to evaluate at this time. However, this model predicts that if CS cells are deliberately exposed to DNA damage, such as that produced by UV light under laboratory conditions, defective transcription-dependent repair of such damage is an expected phenotype (13, 14) .
